Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
Strategic Plan
Whats New at the pCPA
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Zeposia (ozanimod)
pCPA File Number:
22096
Negotiation Status:
Under consideration for negotiation
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Celgene Inc.
CADTH Project Number:
SR0714
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable